FR2764292B1 - Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique - Google Patents

Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique

Info

Publication number
FR2764292B1
FR2764292B1 FR9707196A FR9707196A FR2764292B1 FR 2764292 B1 FR2764292 B1 FR 2764292B1 FR 9707196 A FR9707196 A FR 9707196A FR 9707196 A FR9707196 A FR 9707196A FR 2764292 B1 FR2764292 B1 FR 2764292B1
Authority
FR
France
Prior art keywords
dicetonic
therapeutics
application
novel compounds
compounds obtained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9707196A
Other languages
English (en)
Other versions
FR2764292A1 (fr
Inventor
Jean Luc Torregrosa
Norbert Olivier Tembo
Arnoult Sylvie Yannic
Joubert Cecile Boyer
Anita Favrou
Michel Finet
Odile Falson
Billiald Stephanie Desquand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Priority to FR9707196A priority Critical patent/FR2764292B1/fr
Priority to PCT/FR1998/001143 priority patent/WO1998056374A1/fr
Priority to EP98929494A priority patent/EP0988036A1/fr
Publication of FR2764292A1 publication Critical patent/FR2764292A1/fr
Application granted granted Critical
Publication of FR2764292B1 publication Critical patent/FR2764292B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
FR9707196A 1997-06-10 1997-06-10 Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique Expired - Lifetime FR2764292B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9707196A FR2764292B1 (fr) 1997-06-10 1997-06-10 Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique
PCT/FR1998/001143 WO1998056374A1 (fr) 1997-06-10 1998-06-05 Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique
EP98929494A EP0988036A1 (fr) 1997-06-10 1998-06-05 Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707196A FR2764292B1 (fr) 1997-06-10 1997-06-10 Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2764292A1 FR2764292A1 (fr) 1998-12-11
FR2764292B1 true FR2764292B1 (fr) 2000-12-29

Family

ID=9507824

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9707196A Expired - Lifetime FR2764292B1 (fr) 1997-06-10 1997-06-10 Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique

Country Status (3)

Country Link
EP (1) EP0988036A1 (fr)
FR (1) FR2764292B1 (fr)
WO (1) WO1998056374A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11501049A (ja) * 1995-04-04 1999-01-26 グラクソ、グループ、リミテッド イミダゾ〔1,2−a〕ピリジン誘導体
WO1997005871A1 (fr) * 1995-08-09 1997-02-20 Ontogen Corporation Inhibiteurs de la monoxyde d'azote synthetase (nos)
FR2742154B1 (fr) * 1995-12-12 1998-02-13 Innothera Lab Sa Utilisation de derives de tetracycles mono ou dicetoniques, nouveaux composes obtenus et leur application en therapeutique

Also Published As

Publication number Publication date
FR2764292A1 (fr) 1998-12-11
WO1998056374A1 (fr) 1998-12-17
EP0988036A1 (fr) 2000-03-29

Similar Documents

Publication Publication Date Title
FR2607505B1 (fr) Nouveaux derives de piperazinyl-1 pyrimidine, leur preparation et leur application en therapeutique et cosmetique
FI953743A0 (fi) Keratolyyttistä ja/tai finnitaudinvastaista aktiivisuutta omaavia kosmeettisia koostumuksia, niiden valmistus ja käyttö
FR2786482B1 (fr) Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
ATE228845T1 (de) Injektionsformulierungen von avermectinen und milbemycinen
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
CY2291B1 (en) 1H-pyridoa3,4-buindole-4-carboxamide derivatives preparation and application thereof in therapeutics
ZA978089B (en) 3,4-diaryloxazolone derivatives, their methods of preparation, and their use in therapeutics.
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2742151B1 (fr) Utilisation de derives de bicycles mono ou dicetoniques, nouveaux composes obtenus et leur application en therapeutique
FR2741079B1 (fr) Nouveaux composes, derives de cyclodextrine et leur utilisation, notamment en cosmetique
FR2742153B1 (fr) Utilisation de derives tricycliques du 1,4-dihydro-1,4- dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique
FR2742155B1 (fr) Utilisation de derives heteroaromatiques et tricycliques du 1,4-dihydro-1,4-dioxonaphtalene, nouveaux composes obtenus et leur application en therapeutique
FR2608160B1 (fr) Nouveaux derives peptidiques et leur application notamment en therapeutique
FR2764292B1 (fr) Utilisation de derives de tetracycles dicetoniques, nouveaux composes obtenus et leur application en therapeutique
FR2850380B1 (fr) Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2742154B1 (fr) Utilisation de derives de tetracycles mono ou dicetoniques, nouveaux composes obtenus et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
ZA977767B (en) Benzylamine derivatives, their preparation and their application in therapeutics.
GB2332671B (en) Acetals, their preparation and their use
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2792635B1 (fr) Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2774990B1 (fr) Nouveaux peptides, utilisation en therapeutique et compositions pharmaceutiques les renfermant
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique